[{"Assets_0_Q3_USD":97086000.0,"EarningsPerShareBasic_1_Q3_USD":-0.12,"EarningsPerShareBasic_3_Q3_USD":-0.46,"EarningsPerShareDiluted_1_Q3_USD":-0.12,"EarningsPerShareDiluted_3_Q3_USD":-0.46,"NetIncomeLoss_1_Q3_USD":-13418000.0,"NetIncomeLoss_3_Q3_USD":-49099000.0,"StockholdersEquity_0_Q3_USD":37183000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":109846000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":106159000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":109846000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":106159000.0,"Ticker":"CERS","CIK":"1020214","name":"CERUS CORP","OfficialName":"Cerus Corporation Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"830388885.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20171103"}]